Crinetics Pharmaceuticals, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
CRNX on Nasdaq
Industry
Pharmaceutical Preparations
Location
6055 Lusk Blvd., San Diego, CA

Insiders trading volume in the past year

Crinetics Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Perceptive Advisors Llc 10%+ Owner $200M Apr 18, 2022
Richard Scott Struthers President & CEO, Director $39.8M -$1.35M -3.28% Sep 26, 2025
Ajay Madan Chief Development Officer $8.11M Feb 28, 2022
Wendall Wierenga Director $3.87M Jun 11, 2025
Alan Seth Krasner Chief Medical Officer $3.63M Oct 17, 2023
Stephen F. Betz Chief Scientific Officer $3.21M -$3.34M -51% Jun 12, 2025
Jeff E. Knight Chief Operating Officer $3.05M -$273K -8.23% Mar 19, 2025
Dana Pizzuti Chief Med and Dev Officer $2.77M -$2.53M -47.8% Oct 1, 2025
Tobin Schilke Chief Financial Officer $2.03M Mar 10, 2025
Marc Wilson Cfo $1.67M Dec 31, 2024
James Hassard Chief Commercial Officer $1.29M Jul 5, 2024
Matthew K. Fust Director $1.02M -$716K -41.2% Sep 26, 2025
Coelho Rogerio Vivaldi Director $710K Jun 11, 2025
Weston Nichols Director $543K Jun 11, 2025
Camille L. Bedrosian Director $543K Jun 11, 2025
Stephanie Okey Director $543K Jun 11, 2025
Caren Deardorf Director $543K Jun 11, 2025
Isabel Kalofonos Chief Commercial Officer Jan 10, 2025

Recent Insider Transactions by Companies or Individuals for Crinetics Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.